20:26 , May 15, 2019 |  BC Extra  |  Financial News

May 15 Financial Quick Takes: Perceptive leads $60M round for ArcherDx; plus Applied Therapeutics’ IPO, IsoPlexis, Symphogen

ArcherDx completes $60M series B  New investor Perceptive Advisors led a $60 million series B round for ArcherDx Inc. (Boulder, Colo.) that the company plans to use to scale operations, advance its companion diagnostic program...
19:48 , Feb 17, 2017 |  BC Week In Review  |  Financial News

Miragen completes venture financing

MicroRNA company Miragen Therapeutics Inc. (Boulder, Colo.) raised $40.7 million in a private placement immediately prior to the close of its merger with publicly listed Signal Genetics Inc. on Feb. 13 to form Miragen Therapeutics...
23:21 , Nov 3, 2016 |  BC Week In Review  |  Company News

Signal, miRagen deal

miRagen will merge with Signal to form a publicly traded microRNA company focused on hematological malignancies, pathological fibrosis and cardiovascular and neurodegenerative diseases. The surviving entity will retain miRagen's name and trade on NASDAQ. The...
23:20 , Nov 1, 2016 |  BC Extra  |  Company News

miRagen finds public path via Signal merger

miRagen Therapeutics Inc. (Boulder, Colo.) will merge with Signal Genetics Inc. (NASDAQ:SGNL) to form a publicly traded microRNA company focused on hematological malignancies, pathological fibrosis and cardiovascular and neurodegenerative diseases. The surviving entity will retain...
08:00 , Nov 16, 2015 |  BC Week In Review  |  Financial News

miRagen completes venture financing

miRagen Therapeutics Inc. , Boulder, Colo.   Business: Cardiovascular   Date completed: 2015-11-10   Type: Venture financing   Raised: $41 million   Investors: Merck Research Labs Ventures Fund; JAFCO; Brace Pharma Capital; MP Healthcare Venture...
02:25 , Nov 11, 2015 |  BC Extra  |  Financial News

miRagen raises $41 series C

MicroRNA company miRagen Therapeutics Inc. raised $41 million in a series C round co-led by MRL Ventures and JAFCO. Other new investors Brace Pharma Capital and MP Healthcare Venture Management joined existing investors Atlas Venture,...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Financial News

Boulder Ventures Ltd. financial update

VC firm Boulder Ventures is aiming to raise up to $100 million for its sixth fund, according to an SEC filing. Boulder invests in software and applications, IT services, storage and communications and life sciences...
01:06 , Dec 27, 2013 |  BC Extra  |  Financial News

Boulder Ventures raising $100 million for sixth fund

VC firm Boulder Ventures is aiming to raise up to $100 million for its sixth fund, according to an SEC filing. Boulder invests in software and applications, IT services, storage and communications and life sciences...
07:00 , Apr 30, 2012 |  BC Week In Review  |  Financial News

miRagen completes venture financing

miRagen Therapeutics Inc. , Boulder, Colo.   Business: Cardiovascular   Date completed: 4/24/12   Type: Venture financing   Raised: $20 million   Investors: Remeditex Ventures; Atlas Venture; Boulder Ventures; Amgen Ventures; Broadview Ventures  ...
01:04 , Apr 25, 2012 |  BC Extra  |  Financial News

miRagen raises $20 million in series B

MicroRNA company miRagen Therapeutics Inc. (Boulder, Colo.) raised $20 million in a series B round led by new investor Remeditex Ventures. Existing investors Atlas Venture; Boulder Ventures; Amgen Ventures; and Broadview Ventures also participated. Additionally,...